Progressive activity-related dyspnea dominates the clinical presentation of patients afflicted
by chronic obstructive and restrictive lung diseases. This symptom invariably leads to activity …

Background Inhaled medication is the cornerstone of the pharmacological treatment for
patients with asthma and chronic obstructive pulmonary disease (COPD). Several inhaler …

COPD is a chronic disease in which effective management requires long-term adherence to
pharmacotherapies but the level of adhesion to the prescribed medications is very low and …

Objective Coronavirus disease 2019 (COVID-19) represents a novel pneumonia leading to
severe acute respiratory syndrome (SARS). Recent studies documented that SARS-…

Rationale: The mechanisms underlying dyspnea in interstitial lung disease (ILD) and chronic
obstructive pulmonary disease (COPD) are unknown. Objectives: To examine whether the …

Rationale: Patients with chronic obstructive pulmonary disease (COPD) primarily describe
their exertional dyspnea using descriptors alluding to increased effort or work of breathing …

Rationale: Severity of lung hyperinflation is known to influence the extent of dyspnea and
exercise intolerance among patients with chronic obstructive pulmonary disease (COPD) with …

The presence of obesity in COPD appears not to be a disadvantage with respect to dyspnea
and weight-supported cycle exercise performance. We hypothesized that one explanation …

Background Nowadays, there is a considerable gap in knowledge concerning the mechanism(s)
by which long-acting β 2 -agonists (LABAs) and long-acting muscarinic antagonists (…

Despite the availability of guideline recommendations, diagnostic confusion between COPD
and asthma appears common, and often it is very difficult to decide whether the obstruction …